BSX vs COMP · P/E 20, rev $16.75B vs rev $5.63B
Boston Scientific Corp (BSX) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Compass Inc (COMP) is a real estate services company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. COMP currently screens at market cap $3.35B.
Not investment advice. Open the BSX and COMP stock pages for the full models.
Not investment advice.